Between April 1997 and September 2007, 660 patients fulfilled the inclusion criteria (Figure 1): 165 patients with baseline CD4 counts of <200 cells/μL did not receive primary prophylaxis for pneumocystosis; and 279 and 216 patients received primary and secondary prophylaxis, respectively. Here, CD4 is linked to pneumocystosis.